Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways
Lubna Therachiyil(Hamad Medical Corporation), Hesham M. Korashy(Qatar University)
Cited by 37
Related Papers
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation
|Molecular Cancer|2017|216
Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma
|Cell Communication and Signaling|2019|56
Gold-containing compound BDG-I inhibits the growth of A549 lung cancer cells through the deregulation of miRNA expression
|Saudi Pharmaceutical Journal|2018|8
Therapeutic potential of carfilzomib, an irreversible proteasome inhibitor, against acetaminophen-induced hepatotoxicity in mice
|Journal of Biochemical and Molecular Toxicology|2016|7